Clarkston Capital Partners’s Boston Scientific BSX Stock Holding History

Clarkston Capital Partners’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-6,500	Closed	-$620K	–	114
2025 Q4	$620K	Hold	6,500	–	–	0.01%	132
2025 Q3	$635K	Hold	6,500	–	–	0.01%	126
2025 Q2	$698K	Hold	6,500	–	–	0.01%	115
2025 Q1	$656K	Hold	6,500	–	–	0.01%	112
2024 Q4	$581K	Hold	6,500	–	–	0.01%	116
2024 Q3	$545K	Hold	6,500	–	–	0.01%	116
2024 Q2	$501K	Hold	6,500	–	–	0.01%	120
2024 Q1	$445K	Hold	6,500	–	–	0.01%	123
2023 Q4	$376K	Hold	6,500	–	–	0.01%	124
2023 Q3	$343K	Hold	6,500	–	–	0.01%	126
2023 Q2	$352K	Hold	6,500	–	–	0.01%	128
2023 Q1	$325K	Hold	6,500	–	–	0.01%	128
2022 Q4	$301K	Hold	6,500	–	–	0.01%	142
2022 Q3	$252K	Hold	6,500	–	–	0.01%	149
2022 Q2	$242K	Sell	6,500 -153	-2%	-$6.23K	﹤0.01%	157
2022 Q1	$295K	Buy	6,653 +153	+2%	+$6.63K	﹤0.01%	150
2021 Q4	$276K	Hold	6,500	–	–	﹤0.01%	143
2021 Q3	$282K	Hold	6,500	–	–	0.01%	127
2021 Q2	$278K	Hold	6,500	–	–	0.01%	128
2021 Q1	$251K	Buy	+6,500	New	+$246K	﹤0.01%	135

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Clarkston Capital Partners's BSX Position: Q1 2026 in Review

Clarkston Capital Partners sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 6,500 shares — an estimated $620K sold.

Clarkston Capital Partners first reported a position in BSX in Q1 2021 and held it in 20 quarters. The position peaked at $698K in Q2 2025. 1,681 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Clarkston Capital Partners reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
Clarkston Capital Partners sold 6,500 Boston Scientific shares in Q1 2026, an estimated $620K.
Clarkston Capital Partners first reported a position in Boston Scientific in Q1 2021 and held it in 20 quarters.
Clarkston Capital Partners's Boston Scientific position peaked at $698K in Q2 2025.
1,681 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Clarkston Capital Partners's 13F filing for Q1 2026, filed 14 May 2026.